TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A review published in Oncoscience examines how extracellular vesicles, particularly exosomes, transmit molecular signals in normal biology, aging and cancer. It describes possible biomarker and drug-delivery applications, but these remain research directions rather than established clinical tools.
A review published September 30 in Oncoscience examines how extracellular vesicles—small particles that carry molecular messages between cells—are involved in healthy biological functions, aging and cancer. The authors, including University of Lethbridge researchers Ethan Umeris and Igor Kovalchuk, describe similarities and differences in the signals released by aging and cancerous cells, and discuss possible uses in disease detection and treatment that require further research.
Extracellular vesicles, or EVs, transport proteins, lipids and genetic material between cells. The review describes their roles in processes such as tissue repair, immune regulation and maintaining cellular balance. Their contents can change in response to stress, inflammation or disease, potentially affecting cells that receive the signals. The article focuses particularly on exosomes, a well-studied type of EV.
According to research discussed in the review, exosomes released by senescent cells—cells that have stopped dividing—can carry inflammatory molecules and regulatory microRNAs. These signals may alter gene expression in nearby cells and contribute to chronic inflammation or impaired tissue repair, changes associated with aging. The review describes these effects as part of a broader area of research, not as a proven explanation for every feature of aging.
Tumor-derived exosomes can also influence surrounding tissue. The studies covered by the authors associate their cargo with processes that may support immune evasion, blood-vessel formation, metastasis and treatment resistance. The review emphasizes that EV effects depend on the cells that release them and the surrounding environment, so similar molecular signals do not necessarily produce identical outcomes.
Why Cell Signals Matter
The review brings together research on a possible biological connection between aging and cancer: both senescent and tumor cells can release vesicles carrying inflammatory signals, stress-related proteins and genetic material. That overlap may help researchers investigate how changes in cellular communication relate to disease and aging. But the authors also stress that the cargo and effects can differ, making it important to distinguish signals associated with one condition from those shared across several.
EVs are being studied as possible biomarkers because their contents may reflect the state of the cells that release them. If researchers can reliably identify disease-specific patterns, those signals could inform future diagnostic approaches. The particles are also of interest for targeted drug delivery because they transport biological molecules. Neither application is established by this review as a routine clinical method; both require additional research.
Products Worth Considering
Levoit Core 600S-P Smart Air Purifier for Large Rooms
Therabody Theragun Prime 6th Generation Deep Tissue Massage Gun, Navy
LEVOIT Vital Pet Pro Smart Air Purifier
As an affiliate, we earn on qualifying purchases.
From Cell Communication to Disease
EVs are part of how cells communicate, not particles associated only with disease. Under normal conditions, they can contribute to tissue maintenance and immune regulation. Their contents and effects vary with the source cell and its circumstances, which is why the review considers healthy, aging and cancerous cells together rather than treating all vesicles as equivalent.
The paper, titled “Extracellular vesicles in health, aging and disease,” appeared in Volume 13 of Oncoscience. First author Ethan Umeris and corresponding author Igor Kovalchuk are affiliated with the Department of Biological Sciences at the University of Lethbridge. The review synthesizes existing research; it does not report a single new clinical trial or establish that EV-based tests or treatments are ready for patient use.
“Thus, it is important to understand both the overlapping and divergent cargo of senescence-associated and tumor-derived exosomes to identify disease-specific biomarkers and to design targeted therapeutic treatments.”
— The review authors
Questions Before Clinical Use
The review describes research directions, and the supplied report does not establish that EVs can currently diagnose aging-related conditions or cancer, predict an individual patient’s outcome, or deliver treatments safely and effectively. It also does not specify a validated set of disease-specific exosome markers or a clinical test based on them.
Further work is needed to determine how reliably vesicle contents can be measured, how well signals distinguish among conditions, and how results vary with the originating cells and tissue environment. The report provides no clinical trial findings or timeline for testing these proposed uses. The extent to which shared signals reflect a meaningful biological link between aging and cancer also remains an area for investigation.
Research Needed for Applications
The next steps described by the review’s implications are further studies comparing the overlapping and distinct cargo of senescence-associated and tumor-derived exosomes, followed by research to test whether those differences can support reliable biomarkers or targeted delivery. The source material does not announce a specific follow-up study, trial, or timetable.
For now, the paper offers a synthesis of research rather than a change in clinical practice. Any potential diagnostic or therapeutic use will depend on future evidence showing that EV signals can be measured consistently and that proposed applications work in relevant clinical settings.
Key Questions
What are extracellular vesicles?
Extracellular vesicles are small particles released by cells that carry molecules such as proteins, lipids and genetic material to other cells.
What does the review say about exosomes and aging?
It discusses research in which exosomes from senescent cells carry inflammatory molecules and regulatory microRNAs that may affect gene expression in neighboring cells. The review does not establish these signals as the cause of aging.
How might tumor-derived exosomes affect cancer?
Studies reviewed by the authors associate tumor-derived exosomes with processes that may support immune evasion, blood-vessel formation, metastasis and treatment resistance. These are research findings discussed in a review, not proof that every tumor uses the same mechanisms.
Are EV-based tests or treatments available based on this review?
The review discusses biomarkers and targeted drug delivery as potential applications. The supplied report does not establish them as routine clinical tests or treatments, and says more research is needed.
Source: news-medical.net
